01 Increasing Prevalence of Chronic Illnesses An important factor contributing to the growth of the medical imaging phantoms market is the rising prevalence of chronic illnesses, including cancer, cardiovascular diseases, neurological disorders, and chronic respiratory diseases. These conditions necessitate frequent and accurate diagnosis, treatment, and monitoring imaging. As per the World Health Organization (WHO), chronic non-communicable diseases (NCDs) constitute the primary cause of mortality and impairment globally. Chronic illnesses claim the lives of 41 million individuals annually on a global scale, accounting for approximately 71% of all fatalities worldwide.Additionally, the majority of deaths caused by chronic diseases are due to cardiovascular illnesses, with a yearly toll of 17.9 million individuals. Cancers are the second leading cause, resulting in 9.3 million deaths annually. Chronic respiratory diseases account for 4.1 million deaths, while diabetes, including deaths caused by renal disease related to diabetes, causes 2.0 million deaths each year. These disorders contribute to the growing need for medical imaging equipment and phantoms, which are crucial in delivering precise and dependable diagnoses and treatment results.
02 Rising Geriatric Population The surge in the geriatric population is linked to a higher prevalence of age-related illnesses requiring regular medical imaging tests. Due to developments in modern medicine and the healthcare sector, life expectancy has increased to the point where most people can anticipate living well into their sixties and beyond. The aging population of the globe is mostly concentrated in six nations: China, the United States, India, Japan, Germany, and the Russian Federation. These countries collectively account for almost 54% of the global aged population.Moreover, the geriatric population is growing in almost every country worldwide. According to the United Nations Report, the worldwide population of 65 and above reached 771 million in 2022, accounting for around 10% of the global population. Projections suggest that it is expected to increase to a rate of 16% by 2050 and is further predicted to rise to 24% by 2100. This demographic phenomenon is a significant factor in expanding the medical imaging phantoms market.
01 High Purchasing and Maintenance Costs The primary limitation of the medical imaging phantoms market is the high expenses of purchasing and maintaining medical imaging instruments and phantoms. As they necessitate qualified personnel, routine calibration, quality control, and repair, medical imaging devices and phantoms are costly to acquire, install, operate, and maintain. Block Imaging reported that in 2023, the CT scanner had an average price range of USD 80K–300K, while the PET scanner had an average price range of USD 225K–750K.Additionally, the price of medical imaging phantoms fluctuates based on factors such as the phantom's category, composition, dimensions, and intricacy. As per a report by the National Institute of Standards and Technology (NIST) in 2018, the price range for a head phantom was between USD 1,500 and USD 15,000, the price range for a chest phantom was between USD 2,000 and USD 20,000, and the price range for a whole-body phantom was between USD 10,000 and USD 100,000. Moreover, the high costs and maintenance required for medical imaging devices and phantoms may impede their affordability and accessibility, particularly in low- and middle-income nations, thereby hindering market expansion.
01 Technological Advancements The medical imaging and phantoms market is experiencing growth opportunities due to technological advancements, including 3D printing, multimodal imaging, and image-guided radiation therapy (IGRT). The utilization of 3D printing technology allows for the creation of inexpensive, personalized, and lifelike phantoms that accurately replicate the anatomical and physiological characteristics of human tissues and organs.Multimodal imaging integrates various imaging techniques, including CT, MRI, PET, and SPECT, to offer supplementary and all-encompassing data regarding the structure and function of the body. Image-guided radiation therapy (IGRT) uses many imaging modalities, including X-ray, ultrasound, and MRI, to precisely direct and monitor the administration of radiation therapy to the specific tumor site while limiting harm to surrounding healthy tissues. These technologies improve the efficiency and precision of medical imaging devices and phantoms, creating market expansion opportunities.
May 2026 Kyoto Kagaku expanded its medical imaging phantom portfolio with advanced anatomical models designed for AI validation, imaging system calibration, and clinical training applications.
March 2026 CIRS (Computerized Imaging Reference Systems) introduced next-generation imaging phantoms featuring enhanced tissue-equivalent materials and improved simulation accuracy for CT, MRI, ultrasound, and radiation therapy applications.
October 2025 GAMMEX expanded its quality assurance phantom solutions with advanced models designed to support radiotherapy verification, imaging system performance testing, and clinical workflow optimization.
June 2025 3B Scientific introduced new medical imaging training phantoms with improved anatomical realism and compatibility across multiple diagnostic imaging modalities.